Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization CDMO Market Report 2024

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology) – Market Size, Trends, And Global Forecast 2025-2034

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Definition

An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that assists in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to provide the expertise, infrastructure, and resources required for advanced therapy medicinal product development and manufacturing.

The main types of products of advanced therapy medicinal products contract development and manufacturing organization (CDMO) include gene therapy, cell therapy, and tissue engineered. Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This can be done using viral or non-viral vectors to deliver therapeutic genes to target cells in several phases, such as phase I, phase II, phase III, and phase IV for the treatment of various indications, including oncology, cardiology, central nervous system and musculoskeletal, infectious disease, dermatology, endocrine, metabolic, genetic, immunology and inflammation, ophthalmology, and hematology.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented –

1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered

2) By Phase: Phase I, Phase II, Phase III, Phase IV

3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

Subsegments:

1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products

2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy

3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size and growth rate 2025 to 2029: Graph

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size 2025 And Growth Rate

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $5.31 billion in 2024 to $6.22 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to the increasing number of ATMP clinical trials, rising awareness and belief among researchers regarding the benefits of advanced therapy, the presence of several ATMP CDMOs, increasing efforts to develop novel therapies for various diseases, and supportive government initiatives.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $11.53 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to the high investment of CDMOs, a growing number of emerging players in the cell and gene therapy (CGT) sector, increasing grants and investments for the development of cell and gene therapies, increasing pharmaceutical R&D spending, increasing number of clinical trials for ATMPs. Major trends in the forecast period include advancements in AAV biomanufacturing facilities, expansion of cell and gene therapy manufacturing, technological advancements in cell and gene therapy, increasing need for access to advanced platforms and technologies, and incorporating advanced technologies such as CRISPR and next-generation sequencing for heightened accuracy.

Book your 30 minutes free consultation with our research experts

Contact Us

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Driver: Rising Clinical Trial Numbers Fuel Growth In The ATMP CDMO Market

The increasing number of clinical trials is expected to propel the growth of the advanced therapy medicinal products CDMO market going forward. Clinical trials are research studies conducted in humans to evaluate the safety and efficacy of medical interventions such as drugs, treatments, devices, or preventive measures. Clinical trial numbers are rising to meet the increasing demand for innovative treatments and to address a growing global disease burden. With the use of advanced therapy medicinal products, the demand for CDMO manufacturing services rises, leveraging specialized expertise and infrastructure. Clinical trial data aids in optimizing manufacturing, ensuring scalability, and quality maintenance to meet larger clinical and commercial needs. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the overall number of industry clinical trials initiated in the UK per year increased marginally by 4.3%, from 394 in 2021 to 411 in 2022. Therefore, the increasing number of clinical trials is driving the growth of the advanced therapy medicinal products CDMO market.

Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Major Players

Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trend: Transforming Cell Therapy Manufacturing With Innovations In Advanced Therapy Medicinal Products

Major companies operating in the advanced therapy medicinal products CDMO market are developing advanced cell therapy manufacturing services to overcome critical issues in cell therapy manufacturing and speed the development activities of their partners. Cell therapy manufacturing services are contract development and manufacturing organization services that offer services which vary from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company that transforms cells into solutions, launched PluriCDMO, a new business division offering cell therapy manufacturing. It utilizes a patented bioreactor system that allows for 3D cell multiplication, facilitating the production of a variety of cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO desires to provide high-quality, vital medicines to patients while maintaining unique batch-to-batch consistency in a scalable and cost-effective manner in good manufacturing practice settings.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Merger And Acquisition: Recipharm AB Expands Biologic Capabilities With Acquisition Of Vibalogics

In February 2022, Recipharm AB, a Sweden-based contract development and manufacturing organization (CDMO), acquired Vibalogics for an undisclosed amount. The acquisition aims to strengthen Recipharm's position in advanced therapy medicinal products and allow IT to grow into additional biologic modalities such as viral vectors. The deal will enable Recipharm to broaden its technologies and modalities, allowing IT to better service the rapidly growing biopharmaceutical industry demand for specialist CDMO capabilities in viral manufacturing. Vibalogics is a Germany-based virotherapy CDMO manufacturer of oncolytic viruses, viral vaccines, and gene therapies

Regional Outlook For The Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market includes revenues earned by entities by providing services such as process development, analytical method development, good manufacturing practice manufacturing, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products CDMO market also includes sales of bioreactors and fermenters, cryopreservation equipment, and laboratory instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Industry?

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides advanced therapy medicinal products contract development and manufacturing organization (CDMO) market statistics, including the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with advanced therapy medicinal products contract development and manufacturing organization (CDMO) market share, detailed advanced therapy medicinal products contract development and manufacturing organization (CDMO) market segments, market trends, and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry. These advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $6.22 billion
Revenue Forecast In 2034 $11.53 billion
Growth Rate CAGR of 16.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology Subsegments: 1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Characteristics

    3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

    4. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

    5.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis

    5.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

    6. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

    6.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gene Therapy

    Cell Therapy

    Tissue Engineered

    6.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Phase I

    Phase II

    Phase III

    Phase IV

    6.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Cardiology

    Central Nervous System And Musculoskeletal

    Infectious Disease

    Dermatology

    Endocrine, Metabolic, Genetic

    Immunology And Inflammation

    Ophthalmology

    Hematology

    6.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Viral Vectors

    Non-Viral Vectors

    DNA Or RNA-Based Products

    6.5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Autologous Cell Therapy

    Allogeneic Cell Therapy

    Stem Cell Therapy

    6.6. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Skin Substitutes

    Cartilage And Bone Tissue

    Vascular Grafts And Organs

    7. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

    7.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    8.1. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    9.1. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    9.2. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    10.1. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    11.1. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    11.2. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    12.1. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    13.1. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    14.1. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    14.2. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    15.1. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    15.2. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    16.1. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    17.1. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    18.1. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    19.1. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    20.1. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    21.1. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    21.2. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    22.1. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    23.1. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    23.2. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    24.1. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    24.2. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    25.1. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    25.2. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    26.1. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    26.2. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    27.1. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    28.1. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    28.2. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    29.1. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

    29.2. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

    30.1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape

    30.2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Resonac Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

    31.1. Charles River Laboratories International Inc.

    31.2. Recipharm AB

    31.3. KBI Biopharma

    31.4. Takara Bio Inc.

    31.5. Rentschler Biopharma SE

    31.6. Ajinomoto Co. Inc.

    31.7. ElevateBio LLC

    31.8. Fujifilm Diosynth Biotechnologies

    31.9. Axplora Group GmbH

    31.10. WuXi Advanced Therapies Inc.

    31.11. Celonic Group

    31.12. Batavia Biosciences B.V.

    31.13. BioCentriq

    31.14. Cytovance Biologics

    31.15. Andelyn Biosciences

    32. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    34. Recent Developments In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    35. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

    35.1 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Merck KGaA Financial Performance
  • Table 79: Resonac Corporation Financial Performance
  • Table 80: Lonza Group AG Financial Performance
  • Table 81: Catalent Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Merck KGaA Financial Performance
  • Figure 79: Resonac Corporation Financial Performance
  • Figure 80: Lonza Group AG Financial Performance
  • Figure 81: Catalent Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025 – By Service Type (Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)), By Indication (Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications), By Therapy (Cell Therapy, Gene Therapy, RNA-based Therapies), By Application (Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Ceramics Global Market Report 2025 – By Material (Alumina, Titanate, Zirconia, Silicon Carbide), By Application (Monolithic Ceramic, Ceramic Coatings, Ceramic Matrix Composites, Ceramic Filters), By End-user Industry (Electrical and Electronics, Transportation, Medical, Industrial, Defense and Security, Chemical, Other End-user Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Biofuels Global Market Report 2025 – By Fuel Type (Cellulosic Ethanol, Biofuel, Biobutanol, BioDME, Other Fuel Types), By Processing Technology (Thermochemical, Biochemical), By Raw Material (Jatropha, Camelina, Algae, Simple Lignocellulose, Other Raw Materials) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Lead Acid Battery Global Market Report 2025 – By Type (Stationary, Motive), By Construction Method (Flooded, VRLA (Valve Regulated Lead Acid battery)), By End-User (Utility, Transportation, Industrial, Commercial And Residential) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Materials Global Market Report 2025 – By Product Type (Polymers, Metals And Alloys, Glasses, Composites, Ceramics), By Distribution Channel (Direct, Indirect), By Application (Medical Devices, Automotive, Aerospace, Electrical And Electronics, Industrial, Power, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Orthopedic Technologies, Implants, And Regenerative Products Global Market Report 2025 – By Type (Implants, Regenerative Products), By Product (Orthopedic Fixation Devices, Orthopedic Replacement Devices, Orthopedic Prosthetics, Orthopedic Braces And Support Products, Spinal Implants And Surgical Devices, Arthroscopy Instruments, Orth Biologics, Bone Graft Substitutes), By Site (Hip And Pelvis, Foot And Ankle, Knee And Thigh, Hand And Wrist, Shoulder, Arm And Elbow, Spine, Craniomaxillofacial), By Application (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Drug Delivery Systems Global Market Report 2025 – By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types), By Carrier Type (Liposomes, Nanoparticles, Microspheres, Monoclonal Antibodies, Other Carrier Types), By Technology (Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies), By Application (Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS (Central Nervous System), Ophthalmology, Inflammatory Diseases, Infections, Other Applications), By End User (Hospitals, Specialized clinics, Clinical Research And Development Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Advanced Glass Global Market Report 2025 – By Type (Laminated Glass, Tempered Glass, Ceramic Glass, Other Types), By Application (Solar Control, Safety And Security, Optics And Lighting, High Performance, Other Applications), By End-Use (Construction, Infrastructure, Automobiles, Electronics, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market?

An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that assists in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to provide the expertise, infrastructure, and resources required for advanced therapy medicinal product development and manufacturing. For further insights on the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here

How will the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market drivers and restraints affect the market dynamics? What forces will shape the Advanced Therapy Medicinal Products Contract Development And M

The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market major growth driver - Rising Clinical Trial Numbers Fuel Growth In The ATMP CDMO Market. For further insights on the Advanced Therapy Medicinal Produ request a sample here

What is the forecast market size or the forecast market value of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market?

The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market size has grown strongly in recent years. The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $5.31 billion in 2024 to $6.22 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to the increasing number of ATMP clinical trials, rising awareness and belief among researchers regarding the benefits of advanced therapy, the presence of several ATMP CDMOs, increasing efforts to develop novel therapies for various diseases, and supportive government initiatives. The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $11.53 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to the high investment of CDMOs, a growing number of emerging players in the cell and gene therapy (CGT) sector, increasing grants and investments for the development of cell and gene therapies, increasing pharmaceutical R&D spending, increasing number of clinical trials for ATMPs. Major trends in the forecast period include advancements in AAV biomanufacturing facilities, expansion of cell and gene therapy manufacturing, technological advancements in cell and gene therapy, increasing need for access to advanced platforms and technologies, and incorporating advanced technologies such as CRISPR and next-generation sequencing for heightened accuracy. For further insights on the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here

How is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market segmented?

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs For further insights on the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here

Which region has the largest share of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market? What are the other regions covered in the report?

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

Who are the major players in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market?

Major companies operating in the advanced therapy medicinal products CDMO market are developing advanced cell therapy manufacturing services to overcome critical issues in cell therapy manufacturing and speed the development activities of their partners. Cell therapy manufacturing services are contract development and manufacturing organization services that offer services which vary from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company that transforms cells into solutions, launched PluriCDMO, a new business division offering cell therapy manufacturing. It utilizes a patented bioreactor system that allows for 3D cell multiplication, facilitating the production of a variety of cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO desires to provide high-quality, vital medicines to patients while maintaining unique batch-to-batch consistency in a scalable and cost-effective manner in good manufacturing practice settings.. For further insights on the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

What are the key trends in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market?

Major trends in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market include Transforming Cell Therapy Manufacturing With Innovations In Advanced Therapy Medicinal Products. For further insights on the request a sample here.

What are the major opportunities in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market? What are the strategies for the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organ

For detailed insights on the major opportunities and strategies in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market, request a sample here.

How does the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market relate to the overall economy and other similar markets?

For detailed insights on Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) industry?

For detailed insights on the mergers and acquisitions in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) industry, request a sample here.

What are the key dynamics influencing the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market growth? SWOT analysis of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organiz

For detailed insights on the key dynamics influencing the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market growth and SWOT analysis of the Advanced Therapy Medicinal Products Contract Development And Ma request a sample here.